Literature DB >> 3390372

Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB.

R Aasland1, J R Lillehaug, R Male, O Jøsendal, J E Varhaug, K Kleppe.   

Abstract

The receptor-type oncogenes c-erbB2/neu and c-erbB have been found amplified and/or overexpressed in a number of tumours of epithelial origin. We have studied the expression of oncogenes in biopsies from human thyroid tumours. The c-erbB2/neu and c-erbB oncogenes showed two- to three-fold higher levels of RNA in papillary carcinomas and lymph node metastases as well as in one adenoma when compared to non-tumour tissue. The nuclear oncogenes c-myc and c-fos were found to be expressed at varying levels in both non-tumour and tumour tissue. RNA transcripts specific for the platelet-derived growth factor A and B chains and the N-ras oncogene were detected in one anaplastic carcinoma. Neither rearrangements nor amplifications of oncogenes were observed in the thyroid tumours. These data are particularly interesting in light of the recent findings that epidermal growth factor induces proliferation and dedifferentiation of normal thyroid epithelial cells in vitro. We suggest that the epidermal growth factor or other ligands for the c-erbB and c-erbB2/neu receptors may contribute to the development and/or maintenance of the malignant phenotype of papillary carcinomas of the thyroid.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3390372      PMCID: PMC2246566          DOI: 10.1038/bjc.1988.82

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  41 in total

1.  Structure and activation of the human N-ras gene.

Authors:  E Taparowsky; K Shimizu; M Goldfarb; M Wigler
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

2.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

3.  Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes.

Authors:  H Land; L F Parada; R A Weinberg
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962

4.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.

Authors:  T A Libermann; H R Nusbaum; N Razon; R Kris; I Lax; H Soreq; N Whittle; M D Waterfield; A Ullrich; J Schlessinger
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

5.  Factors controlling proliferation and differentiation of canine thyroid cells cultured in reduced serum conditions: effects of thyrotropin, cyclic AMP and growth factors.

Authors:  P P Roger; J E Dumont
Journal:  Mol Cell Endocrinol       Date:  1984-06       Impact factor: 4.102

6.  Expression of cellular oncogenes in human malignancies.

Authors:  D J Slamon; J B deKernion; I M Verma; M J Cline
Journal:  Science       Date:  1984-04-20       Impact factor: 47.728

7.  Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells.

Authors:  Y H Xu; S Ishii; A J Clark; M Sullivan; R K Wilson; D P Ma; B A Roe; G T Merlino; I Pastan
Journal:  Nature       Date:  1984 Jun 28-Jul 4       Impact factor: 49.962

8.  Interaction of epidermal growth factor with receptors on human and porcine thyroid membranes.

Authors:  H Humphries; S Mac Neil; D S Munro; S Tomlinson
Journal:  J Endocrinol       Date:  1984-07       Impact factor: 4.286

9.  The effects of growth factors and serum on DNA synthesis and differentiation in thyroid cells in culture.

Authors:  M C Eggo; L K Bachrach; G Fayet; J Errick; J E Kudlow; M F Cohen; G N Burrow
Journal:  Mol Cell Endocrinol       Date:  1984-12       Impact factor: 4.102

10.  Nucleotide sequence of the human c-myc locus: provocative open reading frame within the first exon.

Authors:  C Gazin; S Dupont de Dinechin; A Hampe; J M Masson; P Martin; D Stehelin; F Galibert
Journal:  EMBO J       Date:  1984-02       Impact factor: 11.598

View more
  18 in total

1.  Image analysis quantitation of immunoreactive retinoblastoma protein in human thyroid neoplasms with a streptavidin-biotin-peroxidase staining technique.

Authors:  J Figge; G Bakst; D Weisheit; O Solis; J S Ross
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

2.  Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors.

Authors:  Cinzia Azzoni; Lorena Bottarelli; Stefano Cecchini; Costanza Lagrasta; Silvia Pizzi; Tiziana D'Adda; Elisa Tamburini; Guido Rindi; Cesare Bordi
Journal:  Virchows Arch       Date:  2011-03-29       Impact factor: 4.064

3.  Eicosapentaenoic acid, but not docosahexaenoic acid, increases mitochondrial fatty acid oxidation and upregulates 2,4-dienoyl-CoA reductase gene expression in rats.

Authors:  N Willumsen; H Vaagenes; O Lie; A C Rustan; R K Berge
Journal:  Lipids       Date:  1996-06       Impact factor: 1.880

4.  Expression of wild-type p53 tumor suppressor gene and its possible involvement in the apoptosis of thyroid tumors.

Authors:  S Kikuchi; H Hiraide; S Tamakuma; M Yamamoto
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

5.  Regulation of phosphorylation of the c-erbB-2/HER2 gene product by a monoclonal antibody and serum growth factor(s) in human mammary carcinoma cells.

Authors:  R Kumar; H M Shepard; J Mendelsohn
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

6.  Analysis of c-erbB2 protein content of human glioma cells and tumor tissue.

Authors:  H H Engelhard; M Wolters; P S Criswell
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

7.  Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies.

Authors:  G D Lewis; I Figari; B Fendly; W L Wong; P Carter; C Gorman; H M Shepard
Journal:  Cancer Immunol Immunother       Date:  1993-09       Impact factor: 6.968

8.  Chronic administration of eicosapentaenoic acid and docosahexaenoic acid as ethyl esters reduced plasma cholesterol and changed the fatty acid composition in rat blood and organs.

Authors:  L Frøyland; H Vaagenes; D K Asiedu; A Garras; O Lie; R K Berge
Journal:  Lipids       Date:  1996-02       Impact factor: 1.880

9.  Low doses of eicosapentaenoic acid, docosahexaenoic acid, and hypolipidemic eicosapentaenoic acid derivatives have no effect on lipid peroxidation in plasma.

Authors:  H Vaagenes; Z A Muna; L Madsen; R K Berge
Journal:  Lipids       Date:  1998-11       Impact factor: 1.880

10.  Anti-apoptotic effects of protein kinase C-delta and c-fos in cisplatin-treated thyroid cells.

Authors:  Antonella Muscella; Loredana Urso; Nadia Calabriso; Carla Vetrugno; Alessio Rochira; Carlo Storelli; Santo Marsigliante
Journal:  Br J Pharmacol       Date:  2009-02-27       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.